Drug Use Investigation Of Gabapentin

Viatris

Status: Completed

Conditions: Epilepsies, Partial

Treatments: Drug: Gabapentin

Study type: Observational

Funder types: Industry

Identifiers

NCT00567268

A9451163

Details and patient eligibility

About

The objective of the this surveillance is to collect information about 1)adverse drug reactions not expected from the LPD (unknown adverse drug reactions), 2) the incidence of adverse drug reactions in this surveillance, and 3) factors considered to affect the safety and/or efficacy of this drug.

Full description

All the patients whom an investigator prescribes the first Gabapentin should be registered consecutively until the number of subjects reaches target number in order to extract patients enrolled into the investigation at random.

Enrollment: 1,273 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

Patients need to be taking Gabapentin in order to be enrolled in the surveillance

Exclusion criteria

Patients not taking Gabapentin

Trial design

1,273 participants in 1 patient group

Gabapentin

Description:

Patients taking Gabapentin

Treatment:

Drug: Gabapentin